Your browser doesn't support javascript.
loading
[The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)].
Matsuda, Hiroshi; Uehara, Tomoya; Okazawa, Hidehiko; Mizumura, Sunao; Yokoyama, Kunihiko; Yoshimura, Mana.
Affiliation
  • Matsuda H; Integrative Brain Imaging Center, National Center of Neurology and Psychiatry.
  • Uehara T; Graduate School of Pharmaceutical Sciences, Chiba University.
  • Okazawa H; Biomedical Imaging Research Center, University of Fukui.
  • Mizumura S; Department of Radiology, Toho University Omori Medical Center.
  • Yokoyama K; Department of PET Center, Public Central Hospital of Matto Ishikawa.
  • Yoshimura M; Department of Radiology, Tokyo Medical University.
Kaku Igaku ; 57(1): 11-21, 2020.
Article in Ja | MEDLINE | ID: mdl-32074551
ABSTRACT
This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2018 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 999 institutions among 1,230 to which the questionnaire had been sent. Fourteen cases of adverse reactions were reported. A total of 1,017,702 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.4. No case of deficient products was reported.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / Radiopharmaceuticals Limits: Humans Language: Ja Journal: Kaku Igaku Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / Radiopharmaceuticals Limits: Humans Language: Ja Journal: Kaku Igaku Year: 2020 Document type: Article